Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks

ClinicalTrials.gov ID: NCT00418145

Public ClinicalTrials.gov record NCT00418145. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 7, 2026, 9:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Oral Megadose Corticosteroid Therapy of Acute Exacerbations of Multiple Sclerosis (OMEGA)

Study identification

NCT ID: NCT00418145
Recruitment status: Terminated
Study type: Interventional
Phase: Phase 3
Lead sponsor: Fred Lublin; Other
Enrollment: 16 participants

Conditions and interventions

Conditions

Multiple Sclerosis

Interventions

IV methylprednisolone Drug
megadose oral methylprednisolone Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 50 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 31, 2003
Primary completion: Sep 30, 2013
Completion: Sep 30, 2013
Last update posted: May 17, 2017

2003 – 2013

United States locations

U.S. sites: 10
U.S. states: 3
U.S. cities: 6

Facility	City	State	ZIP	Site status
University of Medicine and Dentistry of New Jersey	New Brunswick	New Jersey	08901	—
Maimonides Medical Center	Brooklyn	New York	11219	—
The Jacobs Neurological Institute	Buffalo	New York	14203	—
Hospital For Joint Diseases	New York	New York	10003	—
St. Luke's Roosevelt	New York	New York	10019	—
Icahn School of Medicine at Mount Sinai	New York	New York	10029	—
Columbia University Medical Center	New York	New York	10032	—
NY Presbyterian Hospital-Cornell University New York	New York	New York	10065	—
University of Rochester	Rochester	New York	14627	—
University of Vermont, Burlington	Burlington	Vermont	05405	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00418145, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 17, 2017 · Synced May 7, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00418145 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →